A Greek Professor’s research is moving towards the creation of a kind of “vaccine”, which will treat diabetes type 1. Mr. Constantin Polychronakos, Professor in the Departments of Pediatrics and Human Genetics at MacGill University of Canada, and his team are attempting to create a specialized immune-suppressive. It will aim at the lymphocytes that destroy the islets of Langerhans in the pancreas, which produce insulin. Professor Polychronakos, born in Edessa, was nominated as an honorary Doctor in the Faculty of Medicine at the Aristotle University of Thessaloniki. Mr. Polychronakos is internationally recognized for his progressive research on diabetes type 1 and its genetic substrate. He has the patent title for DNA test and for autoimmune diabetes prognosis. He has also submitted applications for six more patent titles in Canada, the U.S.A. and Europe.